CENNA BIOSCIENCES INC
Biotech · Private
Modified P8 (mP8), an 8-amino acid peptide therapeutic that inhibits amyloid-beta production for Alzheimer's disease treatment
- Grants
- $14M
- 16 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Intranasal Delivery of Peptide Drugs to the Brain | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Intranasal Delivery of Peptide Drugs to the Brain | $746,899 | |
| Federal grant | Department of Health and Human Services · Phase I · Small molecule therapeutics for Alzheimer's Disease | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Small molecule therapeutics for Alzheimer's Disease | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Intranasal Delivery of Peptide Drugs to the Brain | $99,960 | |
| Federal grant | Department of Health and Human Services · Phase II · Progressing the Pre-clinical development of P8 for Alzheimer's Disease | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Progressing the Pre-clinical development of P8 for Alzheimer's Disease | $747,850 | |
| Federal grant | Department of Health and Human Services · Phase II · Small molecule therapeutics for Alzheimer's Disease | $999,998 | |
| Federal grant | Department of Health and Human Services · Phase II · Small molecule therapeutics for Alzheimer's Disease | $2,374,496 | |
| Federal grant | Department of Health and Human Services · Phase II · Small molecule therapeutics for Alzheimer's Disease | $999,998 | |
| Federal grant | Department of Health and Human Services · Phase II · Small molecule therapeutics for Alzheimer's Disease | $374,500 | |
| Federal grant | Department of Health and Human Services · Phase II · IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease | $1,750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease | $1,610,358 | |
| Federal grant | Department of Health and Human Services · Phase II · IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease | $101,144 | |
| Federal grant | Department of Health and Human Services · Phase II · Early Clinical Development Of Modified P8 For The Treatment Of Alzheimer's Disease | $1,041,646 | |
| Federal grant | Department of Health and Human Services · Phase II · Early Clinical Development Of Modified P8 For The Treatment Of Alzheimer's Disease | $1,633,354 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2181 | General Counsel AI, Inc. | — | $63M |
| 2182 | GIWOTECH INC. | — | — |
| 2183 | City Therapeutics | — | — |
| 2184 | CENNA BIOSCIENCES INC | — | — |
| 2185 | OCULOGENEX | — | — |
| 2186 | BIOSUPERIOR TECHNOLOGY INC | — | — |
| 2187 | NexImmune, Inc. | — | $35M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Novel Peptides And Uses Thereofapplication
- Novel Peptides And Uses Thereofapplication
- Novel Peptides And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.